VEGFA and hepatocellular carcinoma: Compared with the group that VEGF-A ≤138.30 pg/ml, VEGF-A >138.30 pg/ml indicated higher risk of MVI in HCC patients (OR: 33.088; 95%CI: 12.871–85.057; P <0.001).